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Non-melanoma skin cancer (NMSC) is the most 
common of all cancers. BCC represents about 80% of 
all NMSC thus making it the most common malignan-
cy in the fair skinned population (1). It is more com-
mon than all other human malignancies combined 
(2,3). Incidence of NMSC has been increasing over the 
past several decades, with an estimated 2.1 million 
new patients treated in the US in 2006 (2) thus repre-
senting an enormous medical and financial burden. 
Known risk factors include chronic and intense 
ultraviolet (UV) light exposure as well as phenotypic 
characteristics, such as light complexion (4). Com-
mon sites are regions that are chronically exposed to 
sun such as the head, scalp and neck.
BCC is usually not included in cancer registries, 
which makes estimating the actual prevalence and 
incidence difficult. In certain regions of Australia an 
incidence of as high as 2% per year has been report-
ed (5). A cross-sectional study recently found that the 
worldwide incidence of BCC varies widely with inci-
dence rates as high as >1000/100 000 person-years 
in Australia and <1/100 000 person-years in parts 
of Africa (6). The incidence of BCC continues to in-
crease significantly worldwide (7,8,9). The incidence 
also increases with age. The increased incidence and 
prevalence can also be attributed to an increased 
awareness about the disease both among the public 
and medical practicioners, as well as better access to 
medical services. 
Despite its prevalence, BCC is not often a cause of 
mortality since it rarely metastasizes. Instead, BCC in-
vades and destroys local tissue, sometimes leading to 
disfiguring lesions, significant morbidity, and a need 
for complex surgery (10).
There are different treatment options depend-
ing on the location and extent of the disease. The 
standard treatment is surgical removal with a vari-
able margin of clinically uninvolved surrounding 
skin (11). Surgery is performed by plastic surgeons or 
surgeons of appropriate subspecialities according to 
the location of the lesion. Dermatosurgeons play an 
important role in the surgical treatment of BCC. Cryo-
therapy, photodynamic therapy, radiotherapy, and 
imiquimod are also used. Recently, molecules target-
ing the hedgehog signaling pathway have emerged 
as a possible treatment (10).
So far, there have been no studies on BCC in Slove-
nia. We thought there was a need to conduct a study 
to have a look at BCC within our own communities. 
The data used were from DCL, which is the main der-
matological tertiary institution in Slovenia. DCL also 
has a strong outpatient general dermatology depart-
ment where patients with BCC are diagnosed and 
sometimes treated with cryotherapy or imiquimod 
cream. Patients are sent to the Department of Plas-
tic Surgery or to other surgical specialists for exci-
sion. The DCL also has a dermatosurgical department 
which has been seeing more and more patients in 
recent years.  
The aim of this study was to obtain statistical data 
about the population treated for BCC in Slovenia, the 
type and location of BCC, and the types of treatment 
used. 
Data for all patients treated at the DCL are entered 
in an administrative hospital program, “Hipokrat”. 
The data include a descriptive diagnosis. We wanted 
to retrospectively examine data for a period of 12 
months. The search criterion was the diagnosis of 
“epithelioma” in the period between January 1 and 
December 31, 2010. 
We then reviewed the files and selected only 
those patients that had BCC diagnosed during that 
time period. We included only those patients where 
the pathohistological report confirmed the presence 
of BCC or where the dermatologist made a clinical 
diagnosis and treated the patient with some form of 
local treatment.
The patient parameters included gender, age, and 
the speciality of the doctor who referred the patients. 
We decided to classify the age of patients into the fol-
lowing groups: 30 years old or less, 31-40, 41-50, 51-
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60, 61-70, 71-80, 81 and older. We included data on 
any previous treatment.
We analyzed the approach in the dermatology office, 
namely the use of dermoscopy and tangential biopsy.
We analyzed the size of tumors by diving them 
into two categories – larger or smaller than 2 cm. 
We analyzed the location of the tumor by dividing 
the skin surface in the following regions: face, neck, 
scalp, back, pectoral region and breasts, abdomen, 
arms, shoulders, legs. Data about the type of tumor 
were retrieved from the respective pathohistological 
report. In cases where the dermatologist opted for lo-
cal treatment without pathohistological verification, 
we relied on the dermatologist’s tumor description in 
the patient’s file.
We searched the patients files for any previous BCC 
and divided patients with multiple BCC into catego-
ries of 5 or more than 5, 4, 3 or 2 BCC in their lifetime. 
We included patients with Goltz-Gorling syndrome 
and included data about locally advanced BCC.
We analyzed the type of treatment. Where the 
treatment was surgical excision we included data 
about the speciality of the doctor who performed the 
excision.
Data were then analyzed using Microsoft Excel.
There were 792 patients with BCC treated at the 
DCL during the 12 months we selected. Of those, 
309 (39.0%) were women and 483 (61.0%) were men 
(Table 1).
At the time of diagnosis, 504 (63.6%) patients 
were 71 years or older and 684 (86.4%) were 61 years 
or older. Almost one third of all patients (244; 30.8%) 
were in the age group above 80 years old. Only 3 
(0.4%) patients were younger than 31 years, there 
were 5 (0.6%)  patients in the age group of 31-40, 26 
(3.3%) patients were between 41-50 years old and 74 
(9.3%) were 51-60 years old
Almost half of all patients, (356; 44.9%) were re-
ferred to DCL by a family physician and 436 (55.1%) 
were referred by dermatologists.
Before their appointment at DCL, only 21 (2.7%) 
patients had been previously treated. Of those, 4 
(0.5%) had been treated with imiquimod cream and 
17 (2.2%) surgically.
All lesions were assessed by dermoscopy. More 
than a third of tumors (276; 34.8%) were localized on 
the face, and almost a third on the back (249; 31.4%). 
The third most common location was the pectoral re-
gion and breasts (104; 13.1%). Other locations includ-
ed: 14 (1.8%) tumors in the scalp, 25 (3.2%) tumors on 
the neck, 26 (3.3%) tumors on arms, 36 (4.6%) tumors 
on shoulders, 19 (2.4%) tumors on the abdomen, 43 
(5.4%) tumors on legs.
The majority of tumors were smaller than 2 cm 
(744; 93.9%). Tumor margins were well-defined. 
Table 1. Patient data
Patients Total 792
Sex female 309 / 39.0%
male 483 / 61.0%
Age (years) <31 3 / 0.4%
31-40 5 / 0.6%  
41-50 26 / 3.3%
51-60 74 / 9.3%
>61 684 / 86.4%
Tumor site face 276 / 34.8%
back 249 / 31.4%
pectoral region and 
breast
104 / 13.1%
scalp 14 / 1.8%
neck 25  / 3.2%
arms 26 / 3.3%
shoulders 36 / 4.6%
abdomen 19 / 2.4%
legs 43 / 5.4%
Histological 
type
nodular 589 / 74.4%








Morbus Bowen 14 / 1.8%
Number of 
BCC
>5 240 / 30.3%
4 64 / 8.1%
3 28 / 3.5%
2 112 / 14.1%









52 /  6.6%
cryotherapy 104 /  13.1%
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 Multiple BCCs were common. Almost a third of 
patients (240; 30.3%) had 5 or more BCCs in their lives, 
64 (8.1%) patients had 4 BCC during their lives, 28 
(3.5%) patients had 3, and 112 (14.1%) patients had 2 
BCCs. There was also 1 (0.1%) patient with Goltz-Gor-
ling syndrome.
The most common form of treatment was surgi-
cal excision (624; 78.8%). Other patients were treated 
locally with cryotherapy (104; 13.1%) or locally with 
imiquimod cream (52; 6.6%). 
Tangential biopsy and pathohistological verifica-
tion presurgery were performed in 36 (4.5%) cases. 
None of the tumors were inoperable. Histologically, 
in all operated patients we proved that the clinical 
diagnosis of epithelioma and assessment by dermos-
copy were correct. Of the tumors, 589 (74.4%) were 
nodular, 159 (20.1%) were superficial, 22 (2.7%) were 
mixed (nodular + superficial), 4 (0.5%) were baseo-
squamous. Only 14 (1.8%) patients of those with sur-
gical excision had Morbus Bowen. 
There were 3 (0.4%) patients with a locally ad-
vanced form of BCC with enlarged local lymph nodes 
because of BCC. They were referred for treatment 
to the Ljubljana Oncology Institute. We do not have 
data about their treatment.
This is the first annual retrospective study on BCC 
at DCL. There were 792 cases of newly discovered 
BCC at DCL in 2010. We have not analyzed the inci-
dence and prevalence of BCC in Slovenia. It is hard 
to estimate the incidence in the population as there 
are many dermatologists in the private sector that 
diagnose and treat BCC as well. However, this would 
offer valuable information which we could compare 
to other countries as well as add to global statistics 
about BCC. There are not that many existing preva-
lence studies nor is NMSC usually included in cancer 
registries around the world. However, the Cancer 
Registry of Slovenia includes NMSC and reported an 
incidence rate of 89.5/100 000 for NMSC in men and 
94.1/100 000 for women in 2005-2009 (12).
We have shown that men and people of older age 
had a significantly higher risk of having BCC. There is 
a significant increase in BCC by each decade of life, 
and 86.4% of BCC was found in the population 61 
years old and older, with 95.4% of patients being 51 
years old or older. Also, we have shown that BCC has 
a tendency towards multiplicity. Almost a third of pa-
tients had 5 or more BCC in their lifetimes. This could 
potentially mean that there are people with a distinct 
tendency to having multiple BCC, and when they 
have BCCs they have them higher numbers.
Patients were referred to the DCL exclusively by 
doctors of two specialties, i.e. family physicians and 
other dermatologists. Classified in this study as ‘’sent 
by dermatologist’’ were also patients that were al-
ready patients of the DCL and came for a follow up for 
a previous BCC or other condition when a new BCC 
was discovered. Skin cancers are easily observed as 
they often occur on exposed areas, but less easily rec-
ognized. It would appear that doctors of specialties 
other than family medicine and dermatology are not 
sufficiently familiar with NMSC. They either do not 
recognize the lesion as being cancerous, or they do 
not realize the importance of (early) treatment and 
they do not refer patients. This speaks of the need 
of further educating not only the public but also the 
doctors.
The most common locations were the face, back, 
and pectoral region. Those are sun-exposed areas. It 
would be interesting to see if there is a difference in 
distribution of BCC between the two genders. The 
size of the tumors was relatively small – 93.9% were 
smaller than 2 cm. However, considering that a third 
of lesions were on the face, there can be a significant 
skin defect after surgery that requires a flap. We were 
pleased to see that dermoscopy was used thoroughly 
– all lesions were verified by dermoscopy. It is a meth-
od that has gained popularity in recent years and has 
proven an invaluable tool in the hands of an expert 
dermatooncologist. 
The majority of tumors were nodular (74.4%), 
a fifth were superficial (20.1%), 2.7% were mixed 
(nodular+superficial). Studies have reported different 
incidence rates for different subtypes (13,14). 
In recent years, there has been a considerable 
amount of effort in educating the public about skin 
cancer, but it is mostly oriented towards melanoma 
and pigmented lesions. On its own, BCC has a low risk 
of mortality. However, because it is often situated in 
sun-exposed areas such as the nose and ears and be-
cause it has a tendency to erode local tissue, it can 
lead to patients having extensive surgery. Therefore, 
early diagnosis is important for BCC as well. Raising 
public awareness in a way similar to that for melano-
ma seems reasonable.
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